BG66128B1 - Фармацевтичен състав и използването му за терапевтичен контрол на извънматочна пролиферация на ендометриална тъкан - Google Patents

Фармацевтичен състав и използването му за терапевтичен контрол на извънматочна пролиферация на ендометриална тъкан Download PDF

Info

Publication number
BG66128B1
BG66128B1 BG106584A BG10658402A BG66128B1 BG 66128 B1 BG66128 B1 BG 66128B1 BG 106584 A BG106584 A BG 106584A BG 10658402 A BG10658402 A BG 10658402A BG 66128 B1 BG66128 B1 BG 66128B1
Authority
BG
Bulgaria
Prior art keywords
lhrh antagonist
use according
administered
treatment
short
Prior art date
Application number
BG106584A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG106584A (bg
Inventor
Klaus Diedrich
Wolfgang KUEPKER
Juergen Engel
Hilde Riethmueller-Winzen
Ricardo Felberbaum
Original Assignee
Zentaris Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Ag filed Critical Zentaris Ag
Publication of BG106584A publication Critical patent/BG106584A/bg
Publication of BG66128B1 publication Critical patent/BG66128B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BG106584A 1999-09-23 2002-04-05 Фармацевтичен състав и използването му за терапевтичен контрол на извънматочна пролиферация на ендометриална тъкан BG66128B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15547899P 1999-09-23 1999-09-23
PCT/EP2000/009212 WO2001021194A2 (en) 1999-09-23 2000-09-20 Method for the therapeutic management of endometriosis and fallopian tube obstruction

Publications (2)

Publication Number Publication Date
BG106584A BG106584A (bg) 2003-02-28
BG66128B1 true BG66128B1 (bg) 2011-06-30

Family

ID=22555601

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106584A BG66128B1 (bg) 1999-09-23 2002-04-05 Фармацевтичен състав и използването му за терапевтичен контрол на извънматочна пролиферация на ендометриална тъкан

Country Status (22)

Country Link
EP (1) EP1214086A2 (ja)
JP (2) JP2003509467A (ja)
KR (1) KR100772852B1 (ja)
CN (2) CN1376070A (ja)
AU (1) AU769482B2 (ja)
BG (1) BG66128B1 (ja)
BR (1) BR0014198A (ja)
CA (1) CA2383510A1 (ja)
HK (1) HK1049117A1 (ja)
HU (1) HUP0202741A3 (ja)
IL (1) IL148185A0 (ja)
MX (1) MXPA02002436A (ja)
NO (1) NO331198B1 (ja)
NZ (1) NZ534836A (ja)
PL (1) PL201898B1 (ja)
RU (1) RU2255759C2 (ja)
SK (1) SK3752002A3 (ja)
TR (1) TR200200738T2 (ja)
TW (1) TWI267373B (ja)
UA (1) UA73956C2 (ja)
WO (1) WO2001021194A2 (ja)
ZA (1) ZA200201374B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10157628A1 (de) * 2001-11-26 2003-06-12 Zentaris Ag Injektionslösung eines LHRH-Antagonisten
US7214662B2 (en) 2001-11-27 2007-05-08 Zentaris Gmbh Injectable solution of an LHRH antagonist
KR101749310B1 (ko) 2008-01-24 2017-06-21 에스퍼란스 파마슈티컬스, 인코포레이티드 용해 도메인 융합 구성물 및 이를 제조하고 사용하는 방법
CA2750582A1 (en) * 2009-01-22 2010-07-29 Maatschap Interne Geneeskunde Rijnstate Method for the prophylaxis or treatment of flushing
DK2914633T3 (da) 2012-10-30 2022-03-14 Esperance Pharmaceuticals Inc Antistof/lægemiddel-konjugater og anvendelsesfremgangsmåder
JP6159870B2 (ja) 2013-03-15 2017-07-05 アッヴィ・インコーポレイテッド 月経出血過多および子宮類線維腫の処置に使用するための組成物
CN112261942A (zh) 2018-04-19 2021-01-22 艾伯维公司 治疗重度月经出血的方法
EP3560555A1 (en) * 2018-04-26 2019-10-30 LifeArc A composition for treating one or more estrogen related diseases

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997027863A1 (de) * 1996-01-29 1997-08-07 Schering Aktiengesellschaft Pharmazeutisches kombinationspräparat aus lhrh-analoga und antiöstrogenen zur behandlung von gynäcologischen störungen
US5658884A (en) * 1994-07-22 1997-08-19 The Medical College Of Hampton Roads Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
WO1998055470A1 (en) * 1997-06-05 1998-12-10 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5064939A (en) * 1990-02-06 1991-11-12 The Salk Institute For Biological Studies Cyclic gnrh antagonists
SE9301606D0 (sv) * 1993-05-07 1993-05-07 Per-Christer Oden Composition for the treatment of impaired hair growth
CN1137722C (zh) * 1994-07-22 2004-02-11 汉普顿路医学院 为长期治疗方案确立基础(tonic)卵巢雌激素分泌
DE19513662A1 (de) * 1995-04-08 1996-10-10 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
CN1228708A (zh) * 1996-09-04 1999-09-15 有限会社多特 经口给药用含肽药物组合物
DE19911771B4 (de) * 1999-03-17 2006-03-30 Zentaris Gmbh LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658884A (en) * 1994-07-22 1997-08-19 The Medical College Of Hampton Roads Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
WO1997027863A1 (de) * 1996-01-29 1997-08-07 Schering Aktiengesellschaft Pharmazeutisches kombinationspräparat aus lhrh-analoga und antiöstrogenen zur behandlung von gynäcologischen störungen
WO1998055470A1 (en) * 1997-06-05 1998-12-10 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone

Also Published As

Publication number Publication date
RU2255759C2 (ru) 2005-07-10
SK3752002A3 (en) 2003-06-03
NO20021430L (no) 2002-05-07
AU769482B2 (en) 2004-01-29
HUP0202741A2 (hu) 2003-01-28
TR200200738T2 (tr) 2002-08-21
NZ534836A (en) 2007-07-27
MXPA02002436A (es) 2003-02-12
IL148185A0 (en) 2002-09-12
JP2012051920A (ja) 2012-03-15
BG106584A (bg) 2003-02-28
JP2003509467A (ja) 2003-03-11
TWI267373B (en) 2006-12-01
KR20020035879A (ko) 2002-05-15
NO20021430D0 (no) 2002-03-21
HK1049117A1 (zh) 2003-05-02
BR0014198A (pt) 2002-05-21
PL353244A1 (en) 2003-11-03
HUP0202741A3 (en) 2003-12-29
CN101045155A (zh) 2007-10-03
UA73956C2 (en) 2005-10-17
EP1214086A2 (en) 2002-06-19
AU7779200A (en) 2001-04-24
KR100772852B1 (ko) 2007-11-02
NO331198B1 (no) 2011-10-31
PL201898B1 (pl) 2009-05-29
WO2001021194A2 (en) 2001-03-29
CN1376070A (zh) 2002-10-23
WO2001021194A3 (en) 2002-03-14
ZA200201374B (en) 2002-10-30
CA2383510A1 (en) 2001-03-29

Similar Documents

Publication Publication Date Title
EP0785792B1 (en) Treatment of ovarian estrogen dependent conditions
ES2281551T3 (es) Metodo de prevencion o tratamiento de enfermedades ginecologicas benignas.
Erkkola et al. Role of progestins in contraception
JP2012051920A (ja) 子宮内膜組織の子宮外の増殖、慢性骨盤痛およびファロピウス管閉塞症を治療するための製剤学的組成物、前述の疾病を治療するための医薬を製造するためのｌｈｒｈアンタゴニスト又はｌｈｒｈアンタゴニストおよび活性剤の使用
US7666836B2 (en) Method for the therapeutic management of endometriosis
JP2012077020A (ja) ゲスターゲンとＧｎＲＨアンタゴニストとの組合せ医薬
US20210052692A1 (en) A composition for treating one or more estrogen related diseases
US6106805A (en) Diagnostic composition containing an LH-RH antagonist for hysteroscopy
Rock Gonadotropin-releasing hormone agonist analogs in the treatment of uterine leiomyomas
Bromer et al. Medical treatment options for leiomyomas